高级检索
牛殿吉, 魏新哲. 沈阳市乙肝和丙肝患者肝癌发病情况调查[J]. 中国公共卫生, 2019, 35(3): 358-360. DOI: 10.11847/zgggws1122753
引用本文: 牛殿吉, 魏新哲. 沈阳市乙肝和丙肝患者肝癌发病情况调查[J]. 中国公共卫生, 2019, 35(3): 358-360. DOI: 10.11847/zgggws1122753
Dian-ji NIU, Xin-zhe WEI. Incidence of hepatocellular carcinoma among hepatitis B and hepatitis C patients in Shenyang city[J]. Chinese Journal of Public Health, 2019, 35(3): 358-360. DOI: 10.11847/zgggws1122753
Citation: Dian-ji NIU, Xin-zhe WEI. Incidence of hepatocellular carcinoma among hepatitis B and hepatitis C patients in Shenyang city[J]. Chinese Journal of Public Health, 2019, 35(3): 358-360. DOI: 10.11847/zgggws1122753

沈阳市乙肝和丙肝患者肝癌发病情况调查

Incidence of hepatocellular carcinoma among hepatitis B and hepatitis C patients in Shenyang city

  • 摘要:
      目的  评估2007 — 2016年辽宁省沈阳市乙型肝炎(以下简称乙肝)和丙型肝炎(以下简称丙肝)患者肝癌发病变化趋势。
      方法  收集2007年1月 — 2016年12月沈阳市第六人民医院乙肝和丙肝患者资料,分析其新发肝癌的发病趋势,比较不同性别与年龄患者肝癌发病差异。
      结果  2007 — 2016年沈阳市乙肝和丙肝患者例数逐年增加,由2007年的3 056例增加至2016年的7 524例,但肝癌发病率并未呈明显上升趋势,2008 — 2013年比2007年略有下降,发病率处于5.27 %~5.87 %,2014 — 2016年又略有上升,发病率超过6 %;2007 — 2016年男、女性乙肝和丙肝患者肝癌发病率分别为6.48 %和5.10 %,男性高于女性(χ2 = 24.496,P < 0.01);发病年龄以50~59岁人数居多,发病率为1.97 %,以18~29岁发病率最低,为0.04 %,且各年龄组每年肝癌发病率差异均有统计学意义(均P < 0.05)。
      结论  2007 — 2016年沈阳市乙肝和丙肝患者新发肝癌男女发病趋势不同,发病年龄以50~59岁多见,应针对重点人群加强肝癌的预防与控制。

     

    Abstract:
      Objective  To evaluate the trend of liver cancer in patients with hepatitis B (HB) and hepatitis C (HC) in Shenyang city, Liaoning province from 2007 to 2016.
      Methods  We collected data on all HB and HC patients hospitalized in the Sixth People's Hospital of Shenyang city of Liaoning province from January 2007 through December 2016 and analyzed the incidences of liver cancer among the patients by age and gender.
      Results  The number of HB and HC inpatients in the hospital increased yearly during the 10-year period, with a total number of 3 056 in 2007 and 7 524 in 2016; while, the incidence of liver cancer among the inpatients showed no significant upward trend, with a slightly lower incidence of 5.27% during the period from 2008 to 2013 but a higher rate of 6.22% – 6.66% during the period of 2014 – 2016 compared to the incidence rate of 5.87% in 2007. The male inpatients had a significantly higher incidence of liver cancer than the female inpatients (6.48% vs. 5.10%, χ2 = 24.496; P < 0.01). The liver cancer incidence rate was significantly higher (1.97%) in the inpatients aged 50 – 59 years but lower (0.04%) in those aged 18 – 29 years in comparison with the incidence rate among the inpatients of other age groups (P < 0.05).
      Conclusion  The variation trend of liver cancer incidence rate among male HB and HC inpatients was different from that among the female HB and HC inpatients during the period of 2007 – 2016 and the number of liver cancer incidents was higher among the inpatients at ages of 50 – 59 years. The results suggest that liver cancer prevention and control need to be strengthened in high risk populations.

     

/

返回文章
返回